Corestreet Logo

Galectin Therapeutics Inc (GALT) Insider Trading

Total insider buys:
  • $20,784,867.70
Total insider sells:
  • $17,753,147.64
Most recent insider trade:
  • April 30, 2024
Most active insider trader:
  • Kevin D Freeman
Trader NameDateTitleAmountPriceTypeTotal Value
Jan. 31, 2019Director30,000$5.00Sell$150,000.00
Jan. 29, 2019Director51,500$4.87Buy$250,805.00
Sept. 25, 2018Director2,000$6.10Buy$12,200.00
Sept. 10, 2018Director19,370$6.02Sell$116,607.40
Sept. 7, 2018Director11,000$6.03Sell$66,330.00
Sept. 4, 2018Director11,900$6.58Sell$78,302.00
Aug. 30, 2018Director58,100$6.08Sell$353,248.00
June 25, 2018Director1,000$7.06Buy$7,060.00
June 20, 2018CFO226,000$8.61Sell$1,945,860.00
June 18, 2018Major Shareholder151,860$8.61Sell$1,307,514.60
June 18, 2018Director60,000$9.06Sell$543,600.00
June 15, 2018Director15,475$8.47Sell$131,073.25
June 14, 2018Major Shareholder76,385$8.28Sell$632,467.80
June 13, 2018Director208,140$7.17Sell$1,492,363.80
June 13, 2018COO43,698$7.41Sell$323,802.18
June 13, 2018CEO100,000$7.51Sell$751,000.00
June 11, 2018COO115,054$5.84Sell$671,915.36
June 11, 2018CFO120,000$5.85Sell$702,000.00
June 8, 2018CFO100,000$5.75Sell$575,000.00
June 8, 2018Director110,000$5.88Sell$646,800.00
June 8, 2018CEO70,000$5.86Sell$410,200.00
June 7, 2018COO109,969$5.20Sell$571,838.80
June 5, 2018COO20,831$5.15Sell$107,279.65
June 4, 2018Major Shareholder50,000$5.12Sell$256,000.00
June 1, 2018COO119,200$5.06Sell$603,152.00
May 31, 2018CFO46,651$5.00Sell$233,255.00
April 16, 2018Director4,000$3.58Sell$14,320.00
April 4, 2018CFO3,349$5.00Sell$16,745.00
Feb. 1, 2018Director2,000$4.10Buy$8,200.00
Jan. 26, 2018Major Shareholder244,444$5.43Sell$1,327,330.92
Jan. 25, 2018Director205,144$5.45Sell$1,118,034.80
Dec. 8, 2017Director7,000$1.85Buy$12,950.00
May 23, 2017Director1,000$2.27Buy$2,270.00
Jan. 5, 2016Director1,666$1.72Buy$2,865.52
Aug. 12, 2015CEO2,000$2.00Buy$4,000.00
June 1, 2015Director2,083$2.70Buy$5,624.10
June 1, 2015CEO4,000$2.53Buy$10,120.00
Aug. 19, 2014Director1,000$4.56Buy$4,560.00
Aug. 15, 2014Director1,000$4.70Buy$4,700.00
Aug. 14, 2014CFO1,000$4.55Buy$4,550.00
Aug. 14, 2014CEO4,000$4.46Buy$17,840.00
Aug. 13, 2014CEO1,000$4.42Buy$4,420.00
April 11, 2014Director6,000$11.84Sell$71,040.00
Jan. 13, 2014Chairman100,000$14.84Sell$1,484,000.00
Dec. 4, 2013Director3,000$8.69Buy$26,070.00
Nov. 19, 2013CEO1,000$5.53Buy$5,530.00
Nov. 19, 2013Director2,000$6.55Buy$13,100.00
Nov. 18, 2013CEO1,000$5.80Buy$5,800.00
Nov. 15, 2013Chairman1,000$6.90Buy$6,900.00
June 3, 2013Director1,176$4.21Buy$4,950.96
First«2 of 3»Last

  • Insiders are both buying and selling Galectin Therapeutics Inc stock.

  • The insider traders at Galectin Therapeutics Inc are: Kevin D Freeman, Fund L.P. 10X, Peter G Traber, Jack W Callicutt, James C Czirr, Marc Rubin, Kary Eldred, Harold H Shlevin, Richard A Jr. Zordani, Joel Lewis, Richard E Uihlein, Arthur Greenberg, Theodore Daniel Zucconi, Gilbert F Amelio, Gilbert S Omenn, John F Mauldin, Steven Prelack, and Elissa J Schwartz

  • The most active insider trader at Galectin Therapeutics Inc is Kevin D Freeman with 21 trades.

  • James C Czirr has sold the most Galectin Therapeutics Inc stock with a total value of $5,546,368.61.

  • Richard E Uihlein has bought the most Galectin Therapeutics Inc stock with a total value of $40,416,566.36.

  • The most recent insider trade for Galectin Therapeutics Inc was on April 30, 2024.

  • The single biggest insider buy for Galectin Therapeutics Inc was from Richard E Uihlein with a total value of $20,032,993.68 on May 31, 2019.

  • The single biggest insider sell for Galectin Therapeutics Inc was from Jack W Callicutt with a total value of $1,945,860.00 on June 20, 2018.